A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

201964 citationsJournal Articlegold Open Access

Authors

EudraCT Number: 2013-003894-87; registered 09-September-2013.

Good health and well-being

Published in: Breast Cancer Research

Volume 22, Issue 1, pp. 1-1

Field-Weighted Citation Impact: 2.53